Innovita Biological Technology Co., Ltd. (SHA:688253)
China · Delayed Price · Currency is CNY 44.68
-0.13 (-0.29%)
At close: Apr 21, 2026
SHA:688253 Market Cap
SHA:688253 has a market cap or net worth of 6.03 billion as of April 21, 2026. Its market cap has increased by 19.87% in one year.
Market Cap
6.03B
Enterprise Value
4.18B
Revenue
422.03M
Ranking
n/a
PE Ratio
41.76
Stock Price
44.68
Market Cap Chart
Since July 28, 2022, SHA:688253's market cap has increased from 4.49B to 6.03B, an increase of 34.21%. That is a compound annual growth rate of 8.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 6.04B | 48.48% |
| Dec 31, 2025 | 4.07B | -17.74% |
| Dec 31, 2024 | 4.95B | 45.41% |
| Dec 29, 2023 | 3.40B | 5.00% |
| Dec 30, 2022 | 3.24B | -27.82% |
| Jul 28, 2022 | 4.49B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| R&G PharmaStudies | 6.59B |
| Lifecome Biochemistry | 6.24B |
| Shouyao Holdings (Beijing) Co., LTD. | 6.24B |
| Kexing Biopharm | 6.17B |
| Shenzhen Weiguang Biological Products | 6.13B |
| Beijing Scitop Bio-tech | 6.12B |
| Novogene | 5.86B |
| Beijing Konruns Pharmaceutical | 5.80B |